FDA Plans For Private-Payer Meetings Ahead, But Roadblocks Remain
This article was originally published in The Gray Sheet
FDA’s device center is recruiting private payers to meet with manufacturers during the pre-submission process to hasten reimbursement. But some experts believe the effort may be hobbled by a lack of common interests.
Register for our free email digests: